These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
677 related articles for article (PubMed ID: 29803768)
41. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy. Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722 [TBL] [Abstract][Full Text] [Related]
42. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma. Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586 [TBL] [Abstract][Full Text] [Related]
43. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Saxena A; Chua TC; Chu FC; Morris DL Am J Surg; 2011 Sep; 202(3):310-20. PubMed ID: 21871986 [TBL] [Abstract][Full Text] [Related]
44. Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Sriputtha S; Khuntikeo N; Promthet S; Kamsa-Ard S Asian Pac J Cancer Prev; 2013; 14(2):1107-10. PubMed ID: 23621195 [TBL] [Abstract][Full Text] [Related]
45. Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis. Reames BN; Ejaz A; Koerkamp BG; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Martel G; Marsh JW; Pawlik TM J Surg Oncol; 2017 Aug; 116(2):133-139. PubMed ID: 28411373 [TBL] [Abstract][Full Text] [Related]
46. [Hilar cholangiocarcinoma: right versus left hepatectomy]. Otto G; Heise M; Hoppe-Lotichius M; Pitton M; Hansen T Zentralbl Chir; 2012 Dec; 137(6):535-40. PubMed ID: 23264194 [TBL] [Abstract][Full Text] [Related]
47. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. Klempnauer J; Ridder GJ; von Wasielewski R; Werner M; Weimann A; Pichlmayr R J Clin Oncol; 1997 Mar; 15(3):947-54. PubMed ID: 9060532 [TBL] [Abstract][Full Text] [Related]
48. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis]. Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027 [TBL] [Abstract][Full Text] [Related]
49. Predictors of Cure of Intrahepatic Cholangiocarcinoma After Hepatic Resection. Tsukamoto M; Yamashita YI; Imai K; Umezaki N; Yamao T; Okabe H; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Yoshizumi T; Maehara Y; Baba H Anticancer Res; 2017 Dec; 37(12):6971-6975. PubMed ID: 29187482 [TBL] [Abstract][Full Text] [Related]
50. [Extent of resection in surgical therapy of central bile duct carcinomas]. Jonas S; Bechstein WO; Kling N; Neuhaus P Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1075-7. PubMed ID: 9574337 [TBL] [Abstract][Full Text] [Related]
51. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma. Ahn CS; Hwang S; Lee YJ; Kim KH; Moon DB; Ha TY; Song GW; Lee SG ANZ J Surg; 2018 Mar; 88(3):212-217. PubMed ID: 27598539 [TBL] [Abstract][Full Text] [Related]
52. [Surgical therapy of intrahepatic cholangiocellular carcinoma]. Lang H; Sotiropoulos GC; Brokalaki E; Frühauf NR; Radü J; Paul A; Wohlschlaeger J; Baba HA; Malagó M; Broelsch CE Chirurg; 2006 Jan; 77(1):53-60. PubMed ID: 16170505 [TBL] [Abstract][Full Text] [Related]
53. Major postoperative complications compromise oncological outcomes of patients with intrahepatic cholangiocarcinoma after curative resection - A 13-year cohort in a tertiary center. Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Tsang SHY; Lo CM Asian J Surg; 2019 Jan; 42(1):164-171. PubMed ID: 29472064 [TBL] [Abstract][Full Text] [Related]
54. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355 [TBL] [Abstract][Full Text] [Related]
55. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. Miyazaki M; Ito H; Nakagawa K; Ambiru S; Shimizu H; Okaya T; Shinmura K; Nakajima N J Am Coll Surg; 1999 Dec; 189(6):575-83. PubMed ID: 10589594 [TBL] [Abstract][Full Text] [Related]
56. Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis. Wang Q; Li J; Lei Z; Wu D; Si A; Wang K; Wang Y; Wan X; Lau WY; Shen F Ann Surg Oncol; 2017 Jun; 24(6):1579-1587. PubMed ID: 28058554 [TBL] [Abstract][Full Text] [Related]
57. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Neuhaus P; Thelen A; Jonas S; Puhl G; Denecke T; Veltzke-Schlieker W; Seehofer D Ann Surg Oncol; 2012 May; 19(5):1602-8. PubMed ID: 21964888 [TBL] [Abstract][Full Text] [Related]
58. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma. Orimo T; Kamiyama T; Mitsuhashi T; Kamachi H; Yokoo H; Wakayama K; Shimada S; Nagatsu A; Taketomi A J Gastroenterol; 2018 Nov; 53(11):1206-1215. PubMed ID: 29721628 [TBL] [Abstract][Full Text] [Related]
59. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372 [TBL] [Abstract][Full Text] [Related]
60. Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma. Conci S; Viganò L; Ercolani G; Gonzalez E; Ruzzenente A; Isa G; Salaris C; Fontana A; Bagante F; Pedrazzani C; Campagnaro T; Iacono C; De Santibanes E; Pinna DA; Torzilli G; Guglielmi A Eur J Surg Oncol; 2020 Sep; 46(9):1727-1733. PubMed ID: 32360063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]